Surrendered on reissue Oct 27, 2020 · High confidence
20-year base term ends Jun 11, 2035
Surrendered on reissue Oct 27, 2020 · its term and maintenance fees continue in US RE48,285 and US RE49,445 and US RE50,497.
Held by GlaxoSmithKline LLC
Filed Jun 11, 2015 as application 14/736,690 · Granted Oct 18, 2016
Base term, 20 years from filing
Today
Surrendered Oct 27, 2020
2015
2035
Clock starts
Jun 11, 2015
Jun 11, 2015
No longer in force
Oct 27, 2020
Oct 27, 2020
Granted
Oct 18, 2016
Oct 18, 2016
Term would have run to
Jun 11, 2035
Jun 11, 2035
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Fees paid on this patent before its reissue. Those after fall due on the reissue, which carries the term on.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 11, 2015, when this application, 14/736,690, was filed | Jun 11, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | no change | High confidence |
| Reissue | US RE48,285 and US RE49,445 and US RE50,497 issued Oct 27, 2020, and this patent's term continues in it (35 U.S.C. 251, 252) | surrendered Oct 27, 2020 | High confidence |
| Surrendered on reissue | The steps above, in order | Oct 27, 2020 | High confidence |
This family
| US 9,469,613 | this patent Oct 2020 | Oct 2020 |
| US 9,809,559 | In force no later than Jun 2035 | no later than Jun 2035 |
| US RE48,285 | In force Jun 2035 | Jun 2035 |
| US RE49,445 | In force Jun 2035 | Jun 2035 |
| US RE50,497 | In force no later than Jun 2035 | no later than Jun 2035 |
| Application 19/245,507 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 6, 2015 Reel 35982, frame 335 | Brown, Brandon H.; Carra, Ernest A.; Hemenway, Jeffrey N.; Morrison, Henry; Reynolds, Troy; Shi, Bing; Stefanidis, Dimitrios; Wang, Fang | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Jul 6, 2015 Reel 35982, frame 447 | Warr, Matthew Robert; Whitney, James Andrew; Xin, Yan | Gilead Sciences, Inc. | Assignment of Assignor's Interest |
| Oct 3, 2018 Reel 47059, frame 834 | Ym Biosciences Australia Pty Ltd. | Sierra Oncology, Inc. | Assignment of Assignor's Interest |
| Oct 18, 2018 Reel 47221, frame 817 | Gilead Sciences, Inc. | Sierra Oncology, Inc. | Assignment of Assignor's Interest |
| May 26, 2023 Reel 63790, frame 568 | Sierra Oncology, Inc. | Sierra Oncology LLC | Change of Name |
| Jun 7, 2023 Reel 63879, frame 821 | Sierra Oncology LLC | GlaxoSmithKline LLC | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
12
later US patents cite this one
That is above the median of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.